Zomedica Pharmaceuticals Corp. (
TSX: V.ZOM,
ZOMHF,
Forum), said its shares have been approved for listing by NYSE American. Trading of the common shares on the NYSE American will not commence until after Zomedica’s Registration Statement on Form S-1 is declared effective by the U.S. Securities and Exchange Commission.
With U.S. operations based in Ann Arbor, Michigan, Zomedica is a veterinary pharmaceutical and health care solutions company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica is developing a diversified portfolio to include diagnostics, devices, innovative drugs, and drug-delivery technologies.
More information can be found
here.
Zomedica was in the news recently when the company announced its financial results for the three and nine months ended September 30, 2017.
Full Disclosure: Zomedica Pharmaceuticals Corp. is a paid client of Stockhouse Publishing.